glp-1 after bariatric surgery Weighted percent weight loss over time following and GLP-1 Receptor Agonists After Bariatric

#obesity #glp1 #healthcareinnovation #healthcaredata To view or add a comment, sign in More Relevant Posts Large Study of Medicare Patients with DFUs Reveals Benefits of DHACM in Reducing Amputations and Long-Term Health-Care Costs To view or add a comment, sign in A Life-Saving Opportunity for Communities Like 78207 New analysis shows that expanding Medicaid coverage for GLP-1 drugs (like Ozempic and Wegovy) across all states could save countless livesand may be far more affordable than we think

Lean Mass Preservation: The Non-Negotiable Preserve Phase Lean mass preservation is essential during midlife GLP-1 therapy because estrogen decline already accelerates muscle loss

Published case reports and expert consensus from gastroenterology societies indicate that patients with resolved diverticulitis and no ongoing inflammation tolerate semaglutide well in follow-up studies

Obesity is a known risk factor for breast cancer, so could some women reduce their odds of this common cancer by taking weight-loss drugs such as Wegovy and Zepbound

Not only could that mean a loss of muscle mass, but a slower metabolism, too

On top of that, he says that patches often struggle to deliver consistent medication levels when the molecular structure is large or when patients require higher doses